About Qure.ai
Qure.ai is a company based in Mumbai (India) founded in 2016 by Prashant Warier. Qure.ai has raised $122.66 million across 8 funding rounds from investors including Merck, Lightspeed Venture Partners and 360 One. The company has 227 employees as of February 04, 2025. Qure.ai offers products and services including qXR, qTrack, Chest X-ray Reporting, Lung Nodule Management, and Stroke & TBI. Qure.ai operates in a competitive market with competitors including AIdoc, Viz.ai, Subtle Medical, Perspectum and Zebra Medical Vision, among others.
- Headquarter Mumbai, India
- Employees 227 as on 04 Feb, 2025
- Founders Prashant Warier
- Stage Minicorn
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Qure.Ai Technologies Private Limited
- Date of Incorporation 19 Jul, 2016
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$17.99 M (USD)68.73as on Mar 31, 2024
-
Net Profit
-$5.59 M (USD)38.47as on Mar 31, 2024
-
EBITDA
-$5.53 M (USD)44.33as on Mar 31, 2024
-
Total Equity Funding
$122.66 M (USD)
in 8 rounds
-
Latest Funding Round
$65 M (USD), Series D
Sep 23, 2024
-
Investors
Merck
& 46 more
-
Employee Count
227
as on Feb 04, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Qure.ai
Qure.ai offers a comprehensive portfolio of products and services, including qXR, qTrack, Chest X-ray Reporting, Lung Nodule Management, and Stroke & TBI.
AI for analyzing chest X-rays to detect tuberculosis early.
Platform for healthcare screening and case management programs.
Tools to report and manage chest X-ray results for diseases.
AI system for tracking lung nodules and disease progression.
AI suite for stroke triage and timely clinical interventions.
People of Qure.ai
Unlock access to complete
Unlock access to complete
Funding Insights of Qure.ai
Qure.ai has successfully raised a total of $122.66M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $65 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Qure.ai
Qure.ai has secured backing from 47 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Merck, Lightspeed Venture Partners and 360 One.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate-backed venture capital is focused on the life science sector.
|
Locked | Locked | Locked | |
|
Early-stage investing in tech startups in India.
|
Locked | Locked | Locked | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Locked | Locked | Locked |
Investor details for Qure.ai
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Qure.ai
Investment portfolio details for Qure.ai
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Qure.ai
Detailed financials for Qure.ai
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Qure.Ai Comparisons
Peer comparison for Qure.ai
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Qure.ai
Qure.ai operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AIdoc, Viz.ai, Subtle Medical, Perspectum and Zebra Medical Vision, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based single-screen system is provided to streamline medical imaging.
|
|
| Locked | Locked | Locked |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| Locked | Locked | Locked |
AI-driven solutions for medical diagnostic imaging are developed.
|
|
| Locked | Locked | Locked |
Precision medicine software for liver disease diagnosis is offered.
|
|
| Locked | Locked | Locked |
Provider of AI and SaaS-based medical image based decision support tools
|
Detailed competitors of Qure.ai
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Qure.Ai
Complete news archive for Qure.ai
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Qure.ai
Qure.ai was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Qure.ai is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Prashant Warier is the current CEO of Qure.ai. They have also founded this company.
Qure.ai is a funded company, having raised a total of $122.66M across 8 funding rounds to date.
As of Feb 04, 2025, the latest employee count at Qure.ai is 227.
Annual revenue of Qure.ai is $17.99M as on Mar 31, 2024.
Qure.ai was founded in 2016 in Mumbai, India, within the healthcare technology sector. Operations center on AI-driven tools that support diagnostics through deep learning analysis of X-rays, CT scans, and MRIs. Early detection and management of tuberculosis, lung cancer, stroke, and COVID-19 are facilitated for healthcare professionals across various global settings.
Qure.ai's top competitors include Perspectum, AIdoc and Subtle Medical.
Qure.ai offers qXR, qTrack, Chest X-ray Reporting, Lung Nodule Management, and Stroke & TBI.
Qure.ai has 47 investors. Key investors include Merck, Lightspeed Venture Partners, 360 One, Kae Capital, and Peak XV Partners.
The valuation of Qure.ai is $220.27M as of May 2024.